Taking stock of the drug industry, from the lab to the medicine chestAugust 25, 2023Check out STAT+Sponsored By By Ed SilvermanPharmalot Columnist, Senior Writer Adobe STAT+ | Weight loss drug Wegovy improves function in people with common type of heart failure Novo Nordisk's weight loss drug improved symptoms and quality of life for patients with a common heart condition, a new study shows. By Elaine Chen STAT+ | AstraZeneca sues to stop Medicare drug price negotiation program AstraZeneca filed a lawsuit to challenge a new Medicare drug price negotiation program set to kick off next week. By Rachel Cohrs U.S. health officials lay out plans to cope with respiratory virus season This year, as last, older adults and people who have immunocompromising health conditions will be able to get a second dose of Covid vaccine. By Helen Branswell OSCAR DEL POZO/AFP via Getty Images Opinion: Surfing, camping, and deciding when to stop: Australia's human-centric approach to dialysis This excerpt from Tom Mueller's "How to Make a Killing" shows Australia and America have traveled very different paths in dialysis. By Tom Mueller STAT+ | NYU launched private ChatGPT for its health data, and set its staff loose to experiment NYU Langone is embracing broad experimentation with ChatGPT, hoping that in the long run it might lead to improvements in efficiency and patient care. By Mario Aguilar More around STATCheck out more exclusive coverage with a STAT+ subscriptionRead premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.Enjoying Pharmalot? Tell us about your experienceContinue reading the latest health & science news with the STAT appDownload on the App Store or get it on Google Play STAT, 1 Exchange Place, Boston, MA©2023, All Rights Reserved.I no longer wish to receive STAT emailsUpdate Newsletter Preferences • Contact Us • Advertise with Us • View in Browser
No comments